טוען...
Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain
INTRODUCTION: Chronic pain is an important yet overlooked non-motor symptom of Parkinson’s disease (PD), caused by an imbalance of the dopaminergic and glutamatergic systems. Safinamide has a multimodal mechanism of action, dopaminergic (reversible MAO-B inhibition) and non-dopaminergic (modulation...
שמור ב:
| הוצא לאור ב: | Adv Ther |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Healthcare
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5910467/ https://ncbi.nlm.nih.gov/pubmed/29542008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-018-0687-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|